The authors propose that thalidomide can mitigate inflammation in idiopathic pulmonary fibrosis, and can be repurposed either as monotherapy or in combination with nintedanib and pirfenidone.
[Inflammopharmacology]
Thalidomide Interaction with Inflammation in Idiopathic Pulmonary Fibrosis
